She has been taking colchicine without symptom recurrence and is currently continuing GnRH antagonist therapy. After using a GnRH antagonist for six months, she switched to DNG to control menstruation, which resumed promptly without peritonitis associated with the menstrual cycle, unlike during the previous treatment attempt. The gene discussed is GNRH1; the disease is peritonitis.